Therefore, we used a genetically engineered CRC mouse model containing the Apc knockdown, KrasG12D activation, and P53 mutations (37, 69) where small intestinal organoids have been shown to have multiple cell lineages and recapitulate organ physiological parameters. This evidence concerns the gene TP53 and colorectal carcinoma.